Expert Video - Why might TIL therapy not be recommended for me?

Dr. Rekha Chaudhary, a medical hematologist-oncologist and assistant professor of medicine at the University of Cincinnati, explains that tumor infiltrating lymphocyte (TIL) therapy is an intensive process and may not be recommended for every patient. Your doctor will determine if you are healthy enough to undergo this treatment. Talk to your doctor about whether TIL therapy could be an option for you.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about melanoma which will help other patients, caregivers and families.

Other Modules:


This educational activity has been developed by the Melanoma Research Foundation (MRF), and Mechanisms in Medicine Inc.

This activity is supported by independent educational grants from Bristol-Myers Squibb, Foundation Medicine, Genentech, Iovance Biotherapeutics, Merck, Natera, and Novartis.

Bristol-Myers Squibb
Foundation Medicine

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.